Because dasatinib is related to significant myelosuppression, patients that ingest over the encouraged dosage needs to be monitored intently for myelosuppression and receive proper supportive treatment.7 In the event of persistent PE severity, CXR monitoring needs to be performed as described above. When the symptoms persist or worsen, the administration https://josephp530fjn2.wikitelevisions.com/user